http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-273934-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30432c021c19453629a3b69ce104640e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 1962-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1962-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-273934-A1
titleOfInvention A PROCEDURE FOR THE PRODUCTION OF LOWER 4,6-DIAMINE-1,2-DIHYDRO-2-ALCOHYL SALTS-1-ARYL-S-TRIAZINES
abstract The invention comprises salts of triazines of formula <FORM:0986811/C2/1> with 4,41-methylene bis(3-hydroxy-2-napthoic acid) where X is hydrogen, halogen, methyl or trifluoromethyl, each of Y and Z is hydrogen, halogen, lower (i.e. 1-4 C) alkyl, lower alkoxy, lower alkylthio, trifluoromethyl or benzyloxy, at least one of X, Y and Z being hydrogen R1 is lower alkyl and R2 is hydrogen or methyl the salts are prepared by reaction of the components or salts thereof in a solvent. Triazines I may be prepared by reaction of the X,Y,Z-aniline with dicyandiamide and a compound R1R2.CO in the presence of a strong acid: if the compound R1R2.CO is reacted in a second step a biguanide of formula <FORM:0986811/C2/2> (e.g. p-chlorophenylbiguanide hydrochloride) is first obtained. Pharmaceutical compositions containing the above triazine salts are mentioned for parenteral administration (as suspensions) against bacteria and malaria. Reference has been directed by the Comptroller to Specification 709,906.
priorityDate 1961-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421972151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419763501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15184872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID458746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451068593

Total number of triples: 28.